WHO Guidance on Weight Loss Injections for Children Under 10

This content outlines the World Health Organization's new advice regarding the use of weight loss injections, such as Mounjaro and Wegovy, for children under the age of 10. It clarifies current licensing status, ongoing trials, and recommended approaches for managing childhood obesity across different age groups.

- WHO stance on weight loss drugs for children under 10: Focus on healthy eating and exercise rather than medication due to insufficient evidence.
- Licensing and off-label use: Most drugs are licensed for older children and teenagers; some doctors prescribe them off-label, and trials are testing effects on children as young as six.
- Global obesity context: Approximately 170 million children and teenagers worldwide are obese, increasing risks for diseases like type 2 diabetes.
- Recommendations for older children: Medicines may be considered if other approaches fail and the child is mentally and physically ready.

Viewers seeking to understand current medical guidelines and global statistics on childhood obesity will gain clarity on when pharmaceutical interventions are appropriate versus when lifestyle changes are prioritized.